The stock of SinglePoint, Inc (OTCMKTS:SING) closed at $0.073 losing 8.25% in yesterday’s trading session. This provider has recently been seen to pay much focus to accelerated growth in Cannabis sector and it targets to make its impact felt...

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) happens to be a biopharmaceutical provider focusing on the discovery, development as well as the commercialization of a wide spectrum of therapeutics from its proprietary cannabinoid product platform. The...

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) CEO Justin Gover will present at the upcoming Cowen and Company Annual Healthcare Conference on March 8, 2017. Several new drugs and therapies are being advanced at a rapidly increasing pace in the Cannabidiol...

Goldman Sachs initiated coverage on GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) with a “Buy” rating and price target of $189. Four other groups lately updated their coverage. The target range as noted from the released reports is from $135...

The American Epilepsy Society’s 70th Annual Meeting was an important one for GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), as it sent off 2016 with its positive Epidiolex® (cannabidiol or CBD) Phase 3 data. The company said that the data it...

Justin Gover, the CEO of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), said that in FY2016, the company has closed three promising Phase III studies for Epidiolex in subjects with two different rare cure resistant types of childhood-onset epilepsy...